ADMA Biologics Shares Rise 25% After Higher Third-Quarter Results
ADMA Biologics reported third-quarter revenue of $141.1 million, compared with $134.2 million a year earlier. Its shares were up 25% at $13.06 in morning trading.
By Chris WackADMA Biologics shares rose after the company reported higher third-quarter revenue and earnings.The stock was 25% higher, at $13.06, in morning trade, but is still down 15% in the past 12 months.Revenue for the quarter was $141.1 million, compared with $134.2 million in the same quarte…